152 related articles for article (PubMed ID: 2417255)
1. Substance P modulation of the mesolimbic dopamine system.
Kalivas P
Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
[TBL] [Abstract][Full Text] [Related]
2. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin in the ventromedial mesencephalon of the rat: anatomical and functional considerations.
Kalivas PW
J Comp Neurol; 1984 Jul; 226(4):495-507. PubMed ID: 6086729
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
Kalivas PW
J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084
[TBL] [Abstract][Full Text] [Related]
5. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
Kalivas PW; Bronson M
Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
[TBL] [Abstract][Full Text] [Related]
6. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
Kalivas PW; Duffy P
J Pharmacol Exp Ther; 1987 Apr; 241(1):204-12. PubMed ID: 3572784
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
Heidbreder C; Feldon J
Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
Kalivas PW; Richardson-Carlson R; Duffy P
J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
[TBL] [Abstract][Full Text] [Related]
9. Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat.
Riegel AC; Ali SF; Torinese S; French ED
Ann N Y Acad Sci; 2004 Oct; 1025():543-51. PubMed ID: 15542760
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
[TBL] [Abstract][Full Text] [Related]
12. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
Debonnel G; de Montigny C
Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
[TBL] [Abstract][Full Text] [Related]
13. Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1982 Apr; 21(4):327-35. PubMed ID: 7201088
[No Abstract] [Full Text] [Related]
14. Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine injection in the rat ventral tegmental area.
Sánchez MS; Barontini M; Armando I; Celis ME
Cell Mol Neurobiol; 2001 Oct; 21(5):523-33. PubMed ID: 11860189
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
16. A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: modulation by neurotensin.
Kalivas PW; Jennes L; Miller JS
Brain Res; 1985 Feb; 326(2):229-38. PubMed ID: 2857589
[TBL] [Abstract][Full Text] [Related]
17. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
18. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
19. Behavioral implications of dopaminergic neurons in the mesolimbic system.
Iversen SD; Koob GF
Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
[No Abstract] [Full Text] [Related]
20. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
Brudzyński SM; Mogenson GJ
Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
